CHIMERIX, INC. - Common Stock, par value $0.001 per share (CMRX)

CUSIP: 16934W106

Q2 2023 13F Holders as of 30 Jun 2023

Holder snapshot 7 signals
Share change
-13,844,136
Put/Call ratio
86%
SEC-reported price per share
$1.21
Number of holders
95
Value change
-$17,344,774
Number of buys
52
Open additional details 1 more signal available
Number of sells
57
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
94,458,399

Security key

16934W106

Report period

Q2 2023

Institutions

95

Top holders

10

Ownership snapshot

Top reported holders of CMRX - CHIMERIX, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
CANTEX PHARMACEUTICALS, INC.
Disclosed value leader
Rubric Capital Management LP
Comparable rows
0/15
Latest evidence
31 Mar 2023
3/4/5 13F Highest disclosed value: $9,244,286 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Rubric Capital Management LP has the largest disclosed position value at $9.24M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Rubric Capital Management LP's linked filing trail.
Disclosed position value Top 5
CANTEX PHARMACEUTICALS, INC. $3.34M
Rubric Capital Management LP $9.24M
BlackRock Finance, Inc. $6.16M
VANGUARD GROUP INC $5.74M
ARMISTICE CAPITAL, LLC $4.13M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
CANTEX PHARMACEUTICALS, INC.
3/4/5
10%+ Owner
—
denominator unverified
$3,343,550
3,500,000 shares
— 14 Sep 2021
Rubric Capital Management LP
13F
Company
13F
—
denominator unverified
$9,244,286
7,336,735 shares
— 31 Mar 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$6,155,616
4,885,409 shares
— 31 Mar 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$5,740,276
4,555,775 shares
— 31 Mar 2023
ARMISTICE CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$4,127,760
3,276,000 shares
— 31 Mar 2023
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$3,363,193
2,669,201 shares
— 31 Mar 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
95
Shares
39,222,332
Rows available
95
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q3 2025 Across Filers

Q3 2025 holders
0
Q2 2023 holders
95
Holder diff
95
Investor Q3 2025 Shares Q2 2023 Shares Share Diff Share Chg % Q3 2025 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .